An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

被引：84

作者：

Joly, Berangere S. ^{[1
,2
]}

Coppo, Paul ^{[3
]}

Veyradier, Agnes ^{[1
,2
]}

机构：

[1] Univ Paris Dider, Grp Hosp St Louis Lariboisiere, AP HP, Serv Hematol Biol,Inst Univ Hematol, Paris, France

[2] Univ Paris Dider, Grp Hosp St Louis Lariboisiere, AP HP, Ctr Hayem EA3518,Inst Univ Hematol, Paris, France

[3] Univ Sorbonne Paris Cite, Hop St Antoine, AP HP, Serv Hematol, Paris, France

来源：

EXPERT REVIEW OF HEMATOLOGY | 2019年 / 12卷 / 06期

关键词：

Thrombotic microangiopathy; thrombotic thrombocytopenic purpura; ADAMTS13; von Willebrand factor; autoimmunity; rare disease; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; SEVERE ADAMTS13 DEFICIENCY; FRENCH NATIONAL REGISTRY; UPSHAW-SCHULMAN SYNDROME; MOLECULAR CHARACTERIZATION; CONFORMATIONAL ACTIVATION; ANTI-ADAMTS13; ANTIBODIES; PLASMA-EXCHANGE; FACTOR-VIII;

D O I：

10.1080/17474086.2019.1611423

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, consumption thrombocytopenia, and organ injury. TTP pathophysiology is based on a severe ADAMTS13 deficiency, the specific von Willebrand factor (VWF)-cleaving protease. Areas covered: VWF/ADAMTS13 interaction is specific, and ADAMTS13 conformation has been elucidated recently. ADAMTS13 deficiency is congenital or acquired. Several targets are used in TTP treatment. Expert opinion: Differential diagnosis of TTP may be challenging and ADAMTS13 investigations are needed. ADAMTS13 conformation could be a promising parameter for TTP diagnosis and prognosis in the coming years. Plasma therapy remains the first-line treatment of the acute phase of TTP. Additional curative and preemptive rituximab are used in acquired TTP. Clinical trials dedicated to innovative drugs are promising.

引用

页码：383 / 395

页数：13

共 80 条

[1] IMMUNOHISTOCHEMISTRY OF VASCULAR LESION IN THROMBOTIC THROMBOCYTOPENIC PURPURA, WITH SPECIAL REFERENCE TO FACTOR-VIII RELATED ANTIGEN [J].

ASADA, Y ;

SUMIYOSHI, A ;

HAYASHI, T ;

SUZUMIYA, J ;

KAKETANI, K .

THROMBOSIS RESEARCH, 1985, 38 (05) :469-479

[2] Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study [J].

Bendapudi, Pavan K. ;

Hurwitz, Shelley ;

Fry, Ashley ;

Marques, Marisa B. ;

Waldo, Stephen W. ;

Li, Ang ;

Sun, Lova ;

Upadhyay, Vivek ;

Hamdan, Ayad ;

Brunner, Andrew M. ;

Gansner, John M. ;

Viswanathan, Srinivas ;

Kaufman, Richard M. ;

Uhl, Lynne ;

Stowell, Christopher P. ;

Dzik, Walter H. ;

Makar, Robert S. .

LANCET HAEMATOLOGY, 2017, 4 (04) :E157-E164

[3] Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center [J].

Benhamou, Y. ;

Boelle, P-Y ;

Baudin, B. ;

Ederhy, S. ;

Gras, J. ;

Galicier, L. ;

Azoulay, E. ;

Provot, F. ;

Maury, E. ;

Pene, F. ;

Mira, J. -P. ;

Wynckel, A. ;

Presne, C. ;

Poullin, P. ;

Halimi, J. -M. ;

Delmas, Y. ;

Kanouni, T. ;

Seguin, A. ;

Mousson, C. ;

Servais, A. ;

Bordessoule, D. ;

Perez, P. ;

Hamidou, M. ;

Cohen, A. ;

Veyradier, A. ;

Coppo, P. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (02) :293-302

[4] Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study [J].

Benhamou, Ygal ;

Paintaud, Gilles ;

Azoulay, Elie ;

Poullin, Pascale ;

Galicier, Lionel ;

Desvignes, Celine ;

Baudel, Jean-Luc ;

Peltier, Julie ;

Mira, Jean-Paul ;

Pene, Frederic ;

Presne, Claire ;

Saheb, Samir ;

Deligny, Christophe ;

Rousseau, Alexandra ;

Feger, Frederic ;

Veyradier, Agnes ;

Coppo, Paul .

AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) :1246-1251

[5] Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? experience of the French thrombotic microangiopathies reference center [J].

Benhamou, Ygal ;

Baudel, Jean-Luc ;

Wynckel, Alain ;

Galicier, Lionel ;

Azoulay, Elie ;

Provor, Francois ;

Pene, Frederic ;

Mira, Jean-Paul ;

Presne, Claire ;

Poullin, Pascale ;

Halimi, Jean-Michel ;

Riviere, Etienne ;

Kanouni, Tarik ;

Seguin, Amelie ;

Mousson, Christiane ;

Servais, Aude ;

Bordessoule, Dominique ;

Perez, Pierre ;

Hamidou, Mohamed ;

Chauveau, Dominique ;

Veyradier, Agnes ;

Coppo, Paul .

AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) :E127-E129

[6] ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura [J].

Bettoni, G. ;

Palla, R. ;

Valsecchi, C. ;

Consonni, D. ;

Lotta, L. A. ;

Trisolini, S. M. ;

Mancini, I. ;

Musallam, K. M. ;

Rosendaal, F. R. ;

Peyvandi, F. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) :1556-1565

[7] Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry [J].

Blombery, P. ;

Kivivali, L. ;

Pepperell, D. ;

McQuilten, Z. ;

Engelbrecht, S. ;

Polizzotto, M. N. ;

Phillips, L. E. ;

Wood, E. ;

Cohney, S. .

INTERNAL MEDICINE JOURNAL, 2016, 46 (01) :71-79

[8]

Camilleri RS, 2008, J THROMB HAEMOST, V6, P331, DOI 10.1111/j.1538-7836.2008.02846.x

[9] A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom [J].

Camilleri, R. S. ;

Scully, M. ;

Thomas, M. ;

Mackie, I. J. ;

Liesner, R. ;

Chen, W. J. ;

Manns, K. ;

Machin, S. J. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) :1792-1801

[10] N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice [J].

Chen, Junmei ;

Reheman, Adili ;

Gushiken, Francisca C. ;

Nolasco, Leticia ;

Fu, Xiaoyun ;

Moake, Joel L. ;

Ni, Heyu ;

Lopez, Jose A. .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (02) :593-603

← 1 2 3 4 5 6 7 8 →